These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19141562)

  • 21. Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains.
    Björck L; Capewell S; Bennett K; Lappas G; Rosengren A
    J Intern Med; 2011 Apr; 269(4):452-67. PubMed ID: 21205025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
    Eur J Public Health; 2007 Apr; 17(2):193-8. PubMed ID: 16798782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.
    Capewell S; Morrison CE; McMurray JJ
    Heart; 1999 Apr; 81(4):380-6. PubMed ID: 10092564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985-2006.
    Kabir Z; Perry IJ; Critchley J; O'Flaherty M; Capewell S; Bennett K
    Int J Cardiol; 2013 Oct; 168(3):2462-7. PubMed ID: 23541608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Dietary Fat Intake and Projections for Coronary Heart Disease Mortality in Sweden: A Simulation Study.
    Björck L; Rosengren A; Winkvist A; Capewell S; Adiels M; Bandosz P; Critchley J; Boman K; Guzman-Castillo M; O'Flaherty M; Johansson I
    PLoS One; 2016; 11(8):e0160474. PubMed ID: 27490257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying options for reducing coronary heart disease mortality by 2020.
    Huffman MD; Lloyd-Jones DM; Ning H; Labarthe DR; Guzman Castillo M; O'Flaherty M; Ford ES; Capewell S
    Circulation; 2013 Jun; 127(25):2477-84. PubMed ID: 23661723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Explaining the decline in coronary heart disease mortality in Portugal between 1995 and 2008.
    Pereira M; Azevedo A; Lunet N; Carreira H; O'Flaherty M; Capewell S; Bennett K
    Circ Cardiovasc Qual Outcomes; 2013 Nov; 6(6):634-42. PubMed ID: 24192571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study.
    Adlerberth AM; Rosengren A; Wilhelmsen L
    Diabetes Care; 1998 Apr; 21(4):539-45. PubMed ID: 9571339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America.
    Capewell S; Ford ES; Croft JB; Critchley JA; Greenlund KJ; Labarthe DR
    Bull World Health Organ; 2010 Feb; 88(2):120-30. PubMed ID: 20428369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment?
    Critchley JA; Capewell S; Unal B
    J Clin Epidemiol; 2003 Jun; 56(6):583-90. PubMed ID: 12873654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Explaining the increment in coronary heart disease mortality in Mexico between 2000 and 2012.
    Arroyo-Quiroz C; O'Flaherty M; Guzman-Castillo M; Capewell S; Chuquiure-Valenzuela E; Jerjes-Sanchez C; Barrientos-Gutierrez T
    PLoS One; 2020; 15(12):e0242930. PubMed ID: 33270684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010.
    Cheng J; Zhao D; Zeng Z; Critchley JA; Liu J; Wang W; Sun J; Capewell S
    BMC Public Health; 2009 Jan; 9():30. PubMed ID: 19159492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are there differences in all-cause and coronary heart disease mortality between immigrants in Sweden and in their country of birth? A follow-up study of total populations.
    Gadd M; Johansson SE; Sundquist J; Wändell P
    BMC Public Health; 2006 Apr; 6():102. PubMed ID: 16630338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
    QJM; 2006 Aug; 99(8):523-30. PubMed ID: 16861717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for coronary heart disease in 55- and 35-year-old men and women in Sweden and Estonia.
    Johansson J; Viigimaa M; Jensen-Urstad M; Krakau I; Hansson LO
    J Intern Med; 2002 Dec; 252(6):551-60. PubMed ID: 12472917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006.
    Rastam S; Al Ali R; Maziak W; Mzayek F; Fouad FM; O'Flaherty M; Capewell S
    BMC Public Health; 2012 Sep; 12():754. PubMed ID: 22958443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.
    Critchley JA; Capewell S
    J Epidemiol Community Health; 2003 Apr; 57(4):243-7. PubMed ID: 12646537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study.
    Bajekal M; Scholes S; Love H; Hawkins N; O'Flaherty M; Raine R; Capewell S
    PLoS Med; 2012; 9(6):e1001237. PubMed ID: 22719232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
    Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.